Newscasts - No pain, no gain: Ozempic’s quest for market share

Gen Digital

11/09/2025 05:01

Click the following link to watch video: https://share.newscasts.refinitiv.com/link?entryId=1_qel1bsqo&referenceId=0e4b4bee-8ec3-11f0-9649-1b11869eac4a_B31&pageId=Newscasts
Source: 'Reuters - General news videos'

Description: The shock success of GLP-1 treatments for obesity carries massive implications for wealthy societies and manufacturers Novo Nordisk and Eli Lilly alike. In this week’s Viewsroom podcast, Breakingviews columnists discuss how this would-be jackpot has companies running to keep up.Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.Learn more about your ad choices. Visit megaphone.fm/adchoices

Short Link: https://lseg.group/3IeDnah

Video Transcript:

Verified transcript not available